These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21541271)

  • 1. The association of age-related maculopathy susceptibility 2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Bessho H; Honda S; Kondo N; Negi A
    Mol Vis; 2011 Apr; 17():977-82. PubMed ID: 21541271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Nakai S; Matsumiya W; Miki A; Honda S; Nakamura M
    Jpn J Ophthalmol; 2019 Sep; 63(5):389-395. PubMed ID: 31376050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual outcome of photodynamic therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy over 5 years of follow-up.
    Miki A; Honda S; Kojima H; Nishizaki M; Nagai T; Fujihara M; Uenishi M; Kita M; Kurimoto Y; Negi A;
    Jpn J Ophthalmol; 2013 May; 57(3):301-7. PubMed ID: 23508554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture, Japan.
    Honda S; Imai H; Yamashiro K; Kurimoto Y; Kanamori-Matsui N; Kagotani Y; Tamura Y; Yamamoto H; Ohoto S; Takagi H; Uenishi M; Negi A
    Ophthalmologica; 2009; 223(5):333-8. PubMed ID: 19478533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo, Japan.
    Honda S; Kurimoto Y; Kagotani Y; Yamamoto H; Takagi H; Uenishi M;
    Jpn J Ophthalmol; 2009 Nov; 53(6):593-597. PubMed ID: 20020237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2).
    Yanagisawa S; Kondo N; Miki A; Matsumiya W; Kusuhara S; Tsukahara Y; Honda S; Negi A
    Mol Vis; 2011; 17():3574-82. PubMed ID: 22219653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy.
    Tanaka K; Nakayama T; Mori R; Sato N; Kawamura A; Mizutani Y; Yuzawa M
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7441-4. PubMed ID: 21896867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy.
    Honda S; Bessho H; Kondo N; Kusuhara S; Tsukahara Y; Negi A
    Mol Vis; 2012; 18():2796-804. PubMed ID: 23213279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.
    Hayashi H; Yamashiro K; Gotoh N; Nakanishi H; Nakata I; Tsujikawa A; Otani A; Saito M; Iida T; Matsuo K; Tajima K; Yamada R; Yoshimura N
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5914-9. PubMed ID: 20574013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polypoidal choroidal vasculopathy].
    Yuzawa M
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis of the ARMS2/HTRA1 region in Japanese patients with typical neovascular age-related macular degeneration or polypoidal choroidal vasculopathy.
    Gotoh N; Yamashiro K; Nakanishi H; Saito M; Iida T; Yoshimura N
    Jpn J Ophthalmol; 2010 Nov; 54(6):609-14. PubMed ID: 21191724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography.
    Teper SJ; Nowinska A; Pilat J; Wylegala E
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():108-113. PubMed ID: 26780119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration.
    Bessho H; Honda S; Kondo N; Kusuhara S; Tsukahara Y; Negi A
    Mol Vis; 2012; 18():121-7. PubMed ID: 22275803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population.
    Park DH; Kim IT
    Jpn J Ophthalmol; 2012 Jan; 56(1):60-7. PubMed ID: 21959923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.
    Nakata I; Yamashiro K; Yamada R; Gotoh N; Nakanishi H; Hayashi H; Akagi-Kurashige Y; Tsujikawa A; Otani A; Saito M; Iida T; Oishi A; Matsuo K; Tajima K; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):794-8. PubMed ID: 22232432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.
    Chen H; Liu K; Chen LJ; Hou P; Chen W; Pang CP
    Mol Vis; 2012; 18():816-29. PubMed ID: 22509112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of elastin gene polymorphism to age-related macular degeneration and polypoidal choroidal vasculopathy.
    Yamashiro K; Mori K; Nakata I; Tsuchihashi T; Horie-Inoue K; Nakanishi H; Tsujikawa A; Saito M; Iida T; Yamada R; Matsuda F; Inoue S; Awata T; Yoneya S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8780-4. PubMed ID: 22003121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Cheng Y; Huang L; Li X; Zhou P; Zeng W; Zhang C
    PLoS One; 2013; 8(1):e53665. PubMed ID: 23326481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.